Supplementary Table 2 from Design and Reporting of Targeted Anticancer Preclinical Studies: A Meta-Analysis of Animal Studies Investigating Sorafenib Antitumor Efficacy

James Mattina, Nathalie MacKinnon, Valerie C. Henderson,Dean Fergusson,Jonathan Kimmelman

crossref（2023）

引用 0|浏览4

暂无评分

摘要

Coding details for construct validity categories in Table 2. Adapted from our previous meta-analysis of the drug, sunitinib (5).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要